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Abstract
β-D-Galactofuranose (Galf) and its polysaccharides are found in bacteria, fungi and protozoa but do not occur in mam-
malian tissues, and thus represent a specific target for anti-pathogenic drugs. Understanding the enzymatic degradation 
of these polysaccharides is therefore of great interest, but the identity of fungal enzymes with exclusively galactofuranosi-
dase activity has so far remained elusive. Here we describe the identification and characterization of a galactofuranosidase 
from the industrially important fungus Aspergillus niger. Phylogenetic analysis of glycoside hydrolase family 43 subfamily 34 
(GH43_34) members revealed the occurrence of three distinct clusters and, by comparison with specificities of characterized 
bacterial members, suggested a basis for prediction of enzyme specificity. Using this rationale, in tandem with molecular 
docking, we identified a putative β-D-galactofuranosidase from A. niger which was recombinantly expressed in Escherichia 
coli. The Galf-specific hydrolase, encoded by xynD demonstrates maximum activity at pH 5, 25 °C towards 4-Nitrophenyl-β-
galactofuranoside (pNP-β-Galf), with a Km of 17.9 ± 1.9 mM and Vmax of 70.6 ± 5.3 µmol min
−1. The characterization of this first 
fungal GH43 galactofuranosidase offers further molecular insight into the degradation of Galf-containing structures and may 
inform clinical treatments against fungal pathogens.
Introduction
The 5-membered ring form of galactose, β-D-galactofuranose 
(Galf) is a key structural component of many pathogens, in 
which glycans containing the sugar can be highly immuno-
geneic1. Despite its presence spanning fungi, bacteria, pro-
tozoa, sponges and green algae2 the monosaccharide is not 
present in mammalian tissue, offering a clear target for ther-
apeutics1–3. The occurrence of Galf differs greatly from its py-
ranoside ring form, which is found widely across mammalian 
biology4. Despite the importance of motives containing this 
monosaccharide, knowledge is limited regarding enzymes 
that are active on glycans containing Galf.
In many fungi Galf is a key structural component of the 
cell wall and is present in secreted molecules, it has been 
shown to drive immunogenic responses in mammals5–8. Galf 
containing polysaccharides are found in pathogens such as 
Mycobacterium tuberculosis, Cryptococcus neoformans and 
Aspergillus fumigatus which combined are responsible for 
over 2 million deaths worldwide per annum5,9,10. Galf can 
constitute either the core or the branched sections of poly-
saccharides. In M. tuberculosis  arabinogalactan (AG), a core 
of ~35 Galf moieties with alternating β-1,5 and β-1,6 linkages 
is decorated with a variety of arabinose branches (Fig. 1A)11–
13. Mycobacterium knockouts of the gene encoding UDP-
galactopyranose mutase are unable to produce Galf and fail 
to proliferate in vitro, showing that galactan synthesis is es-
sential for replication of Mycobacterium14. In Aspergilli the 
predominant Galf containing structure is galactomannan, 
a polysaccharide formed by a α-1,2/α-1,6-linked mannose 
backbone with Galf side chains (Fig. 1B)15–18. The detection of 
this galactomannan is utilised to test for Aspergillus in a clini-
cal setting19. Galactomannan plays a key role in cell integrity 
whereby A. fumigatus mutants lacking the ability to insert 
galactomannan into their cell walls suffer severe growth 
impairment20. Additionally Galf is also found in a variety of 
glycoconjugates: such as O-antigens of Escherichia coli lipo-
polysaccharide21, Klebsiella pneumonia galactan-I repeating 
unit22, lipophosphoglycans and glycoinositolphospholipids of 
leishmaniosis-causing protozoa Leishmania major23 and as 
part of glycoinositolphospholipids  and N- and O-glycans on 
proteins secreted by A.  niger24,25 (Fig. 1C).
In a clinical setting, understanding the turnover of immuno-
genic sugars is of great importance to treating patients with 
invasive symptoms from various fungal infections. Addition-
ally, comprehension of the metabolism of Galf and poly-
saccharides containing it offer opportunities for industrial 
application. Fungi such as A. niger are often utilised as ex-
pression hosts for complex pharmaceuticals with human or 
other mammalian recipients26,27. Therefore considering the 
metabolism of such immunogenic sugars as Galf is important 
when designing such processes to avoid potential immune 
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Figure 1: The presence of Galf throughout the fungal and bacterial kingdoms is not uniform and contains a variety of structures of both 
Galf backbones and Galf side chains, for example. a Structure of M. tuberculosis arabinogalactan fragment, b A. fumigatus galactomannan 
fragment, c N- and O-linked glycans. d Phylogenetic tree of GH43_34 family proteins with distinct clades visualised. Known activities are 
demonstrated as follows: β-galactofuranosidase (yellow circle), α-arabinofuranosidase (green star).
cross-reactivity.
Recently characterized bacterial β-galactofuranosidases 
(Galfases) begun to enter the literature, including Galfases 
specific for Galf as well as bifunctional enzymes with activ-
ity on Galf and Araf28–30. However, research into fungal Gal-
fases is considerably less advanced. A Galfase from A. niger 
has previously been employed as a tool for glycoconjugate 
analysis where proof of concept studies demonstrated the 
enzyme was able to remove Galf from glycoproteins with O-
linked (glucoamylase GAM-1) and N-linked (α-galactosidase 
A) Galf containing glycans31,32. In addition the supernatant 
of A. niger cultures can hydrolyse the biologically relevant 
fungal galactomannan33. However, at a gene level the source 
of this activity lacks complete characterization. A. niger α-L-
arabinofuranosidases AbfA and AbfB from GH families 51 
and 54 have a dual activity and can hydrolyse both pNp-α-
Araf and pNp-β-Galf33 but are not active  on fungal galacto-
mannan, indicating other β-galactofuranosidases remain un-
characterized. While undertaking the work described  here, 
discovery of GH2 family β-galactofuranosidases GfgA and 
GfgB in A. nidulans has been reported, thus identifying the 
first specific fungal β-galactofuranosidases34. The biological 
function of Galfase enzymes in situ remain unclear, however, 
it has been suggested that the breakdown of galactomannan 
and other Galf epitopes may be utilised as a carbon source, 
via degradation by Galfase, during carbon limitation to pro-
duce a source of galactose32. 
One reason for limited understanding of Galfases stems 
from the under examined nature of many large GH fami-
lies. For example, members of GH43-34, comprised to our 
knowledge only 6 biochemically characterized bacterial 
proteins at the time of writing, which all showed either β-ᴅ-
galactofuranosidase or α-ʟ-arabinofuranosidase activity35–37. 
As bi-functionality of Arafases and Galfases seems preva-
lent28,33,34 and Araf and  Galf are structurally similar we hy-
pothesized that fungal Galfases were potentially harboured 
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in GH families containing both Arafases and Galfases. 
Therefore, in this work, we describe how we identified an A. 
niger GH43-34 enzyme, XynD, as a potential Galfase candi-
date via a combination of phylogenetic analysis, structural 
modelling and substrate docking. XynD is known to be ex-
pressed during A. niger interaction with plant biomass, how-
ever the biochemical function of XynD had yet to be eluci-
dated. We express and characterize the enzyme, XynD, and 
demonstrate that the enzyme is specific for Galf. This Gal-
fase enzyme represents the first identified and characterized 
fungal GH43 family galactofuranosidase.
Results 
Phylogenetic analysis of XynD
We aimed to elucidate the role and biochemical activity of 
the GH43-34 enzyme from A. niger. Members of this sub-
family exhibit different biochemical specificities, as either 
galactofuranosidases, arabinofuranosidases or arabinanas-
es. Therefore, we investigated whether biochemical activity 
could be inferred from phylogenetic analysis and compari-
son of characterized enzymes with known activities35,38,39  in 
this subfamily. Catalytic domains of all fungal and bacterial 
entries from GH43-34 on the CAZy database40 were selected 
for phylogenetic analysis. Construction of a phylogenetic 
tree via Maximum likelihood analysis revealed four distinct 
clusters (cluster I-IV) within the family (Fig. 1D). The distri-
bution of sequences over the clusters does not follow the 
evolutionary relationships between species, with a mixture 
of fungal and bacterial sequences found in cluster I and II, 
while cluster IlI and IV comprised only bacterial members. 
For those organisms containing multiple GH43-34 members, 
different enzymes can be located in different clusters. Clus-
ter I contains two arabinofuranosidases (ALJ58905.1 and 
AAO78780.1) whilst cluster II contains one biochemically 
characterized enzyme, a galactofuranosidase (ALJ48250.1). 
Based on this separation, we hypothesize that A. niger XynD 
(An11g03120, GenBank: CAK40644.1), which is also found 
in  cluster II, may have galactofuranosidase activity. Cluster 
IV contained one arabinofuranosidase (AAO78767.1) whilst 
cluster III contained no characterized members. Additionally 
through utilising the CAZy database we identified CBM (Car-
bohydrate Binding Module) protein domains that co-occur 
with GH43-34 members, namely CBM6, CBM13, CBM32, 
CBM42 and CBM66 (Fig. 1). See Fig. S1 for bootstrap values 
and fungal member locations.
Modelling and substrate docking
To investigate the potential activity of A. niger XynD in more 
detail we created a model of the protein’s structure based 
on the crystal structure of GH43-34 arabinofuranosidase 
from Bacteroides thetaiotaomicron BT_3675 (PDB 3QZ4)41. 
Of the crystallised GH43 subfamily 34 members, 3QZ4 gave 
the greatest percentage coverage for modelling (89%), with 
37% sequence identity. GH43 family enzymes display a five-
bladed β-propeller fold42, the presence of this fold was also 
predicted in the XynD model. The XynD model composes 
of a monomer 36.4 kDa in size and aligns with one of the 
monomers of the 3QZ4 dimer macromolecule. No kinetic 
or substrate binding data is available for 3QZ4. Therefore, 
using this model, we applied molecular docking simulations 
to gain insights into the functional binding of potential sub-
strates in the active site. Docking studies showed energeti-
cally favourable binding of galactofuranose to the catalytic 
domain of XynD. Substrate docking suggested five residues 
involved in catalysis that were energetically favourable: Asp-
28, Asp-151, Glu-199, Trp-219 and Arg-286. The first three of 
these (Fig. 2A) correspond with the catalytic Brønsted base, 
pKa modulator and catalytic acid that have  been identified 
in GH43 family members42. Molecular docking of arabinose 
in  the active site demonstrated that interaction between 
this sugar and residues Asp-151 and Glu-199 was lacking and 
thus suggested a specificity for galactofuranose as opposed 
to arabinofuranosidase or galactofuranosidase/ arabinofu-
ranosidase dual activity. Analysis of the substrate binding 
site suggests a restricted binding pocket for galactofuranose 
(Fig. 2B).
In order to understand the roles of residues in XynD the en-
zyme was compared with the crystal structures of related 
enzymes. Comparison of the XynD model with the Cellvibrio 
japonicus alpha-L-arabinanase Arb43A complexed with 
arabinohexaose (1GYE) (Fig. 2C) and Bacillus subtilis arabi-
noxylan arabinofuranohydrolase BsAXH-m2,3 in complex 
with xylotetraose (3C7G) (Fig. 2D), suggested the catalytic 
triad was conserved. Differences were observed between 
these proteins in residues involved in hydrophobic stacking. 
BsAXH-m2,3 contains several residues involved in hydropho-
bic stacking: Phe-244 at the II subsite, Trp160 at the III (-1) 
subsite and Trp-101 at the IV (+1) glycerol containing subsite. 
XynD contains an  equivalent residue for Phe-244 (XynD Trp-
219) and Trp-101 (XynD Trp-86), but not for Trp-160. Align-
ment also identified Arg-286 as an equivalent residue to the 
BsAXH-m2,3 Arg-321 involved in +1 subsite stability. 1GYE 
shares the three conserved catalytic residues with XynD but 
the Phe-114 of 1GYE involved in the high binding affinity of 
the enzyme to arabinan has no corresponding residue in the 
XynD model. These results offer insight into the highly con-
served nature of the catalytic residues, whilst the variation 
of other residues involved in binding is rather variable and 
may potentially play a role in enzyme specificity. Trp-219 is 
found exclusively in Galfase clusters (Fig. S2), whilst the ma-
jority of those in the Arafase clusters contain a Thr-219. This 
suggests a key role played by the residue in determining sub-
strate specificity.
Analysis of the protein surface, pore size and accessibility to 
previously known subsites further confirms a suspected ga-
lactofuranosidase specificity of XynD. When superimposed 
against GH43 arabinoxylan arabinofuranohydrolase from 
BsAXH-m2,3 with bound xylotetraose (3C7G) (Fig. 3A) a loop 
on XynD appears to obstruct the I and II sites resulting in a 
far smaller and shallower binding cleft than BsAXH-m2,3 and 
suggests XynD is not able to bind and process larger arabi-
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Figure 2: a Molecular docking (AutoDock VINA as implemented in YASARA) of galactofuranose (yellow) in a model of A. niger XynD gener-
ated using PDB 3QZ4 as a template. Catalytic residues Asp-28, Asp-151, Glu-199 are displayed in lilac with bonding lengths indicated in Å 
b XynD surface highlighting restricted binding pocket c GH43 C. japonicus alpha-L-arabinase Abf43A (PDB 1GYE) depicted with catalytic 
triad (blue) and arabinohexaose ligand (green) overlaid with catalytic triad of XynD (liliac) and Galf ligand (yellow) d B. subtilis arabinoxylan 
arabinofuranohydrolase BsAXH-m2,3 (PDB 3C7G) depicted with catalytic triad (yellow), glycerol (orange) and xylotetraose ligand (blue) 
overlaid with catalytic triad of XynD (liliac) and Galf ligand (yellow).
noxylan or derived oligosaccharides (Fig. 3B). Further com-
parison with Arb43A (1GYE) (Fig. 3C) again shows a far less 
open binding pocket for XynD when superimposed (Fig. 3D). 
Cloning, expression and purification of XynD
To confirm the activity of XynD experimentally, we heter-
ologous expressed the protein. The predicted signal pep-
tide (residues 1-24) is consistent with transcriptomics data43 
suggesting that XynD is a secreted protein and that XynD 
contains four putative N-glycosylation sites. We therefore 
attempted expression in Pichia pastoris, based on a codon 
optimised cDNA sequence and the pPICZα expression system, 
but initial trails were unsuccessful. Expression was achieved 
in Escherichia coli Rosetta (DE3) as C-terminally His-tagged 
XynD without its signal peptide from a pET21a plasmid. The 
protein was purified via Ni-NTA resin affinity chromatogra-
phy followed by anion exchange chromatography with a final 
yield of 7.7 mg l-1 culture. Analysis of the purified protein on 
SDS-PAGE (Fig. S3) indicates that the recombinant enzyme 
possesses an apparent mass of approximately 35 kDa, which 
is consistent with theoretical molecular weight of 36.3 kDa.
Substrate specificity
The activity of XynD was assessed against a panel of ten 
4-nitrophenyl-conjugated saccharides. After incubation of 
0.5 mg XynD with 1 mM substrate at 25 °C for 2 h, activity 
was observed only against pNP-β-Galf, while no hydrolysis 
was detected of pNP-β-Galp, pNP-β-(1,5)-Galf3, pNP-α-Araf, 
pNP-β-Glc, pNP-α-Glc, pNP-β-Xyl, pNP-β-Xyl2, pNP-β-GlcNAc, 
pNP-βlactose. This analysis confirms that XynD is a galacto-
furanosidase.
Monosaccharide analysis of XynD incubation with galacto-
mannan derived from A. niger strain N402, via HPAEC-PAD, 
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detected no release of Galf and thus suggests XynD is not 
directly involved in degradation of intact galactomannan 
(Fig. S4). This was confirmed via analysis of the presence of 
the Galf epitope in galactomannan via the Platelia Aspergil-
lus galactomannan ELISA assay, the abundance of Galf was 
identical before and after treatment of galactomannan with 
XynD. 
To further test the substrate specificity of XynD, A variety of 
potential substrates were tested. No XynD activity was de-
tected against the β-(1,5)-linked oligosaccharides 4MU-Galf3, 
4MU-Galf4, 4MU-Galf5, 4MU-Galf6, a gift of the  Oka group
44. 
Incubation of XynD with Octyl β-D-Galactofuranosyl-(1,6)-
β-D-galactofuranosyl-(1,5)-β-D-galactofuranoside and Octyl 
β-D-Galactofuranosyl-(1,5)-β-D-galactofuranosyl-(1,6)-β-D-
galactofuranoside, a gift from the Lowary group3 revealed 
no observable activity (by MALDI-ToF MS and TLC analysis) 
against these trisaccharides (Fig. S5). Together these results 
indicate that XynD is not active on β-1,5- or β-1,6-linked Galf 
residues.
N-linked glycans on A. niger proteins have been  described 
to contain terminal α-(1,2)-linked Galf moities45 as well as 
β-linked Galf residues. To assess activity of XynD on  such  oli-
gosaccharides, N-linked glycans (Fig. S6) were isolated from 
Transglucosidase L “Amano” (Amano) as described  previ-
ously45 and purified,  and incubated with XynD. Analysis by 
MALDI-TOF MS (Fig. S7) revealed no observable XynD activ-
ity against the glycans. However, as the glycans consisted of 
a range of structures with mass differences corresponding 
to  one pyranose residue,  assessement of activity was not 
straight forward. The glycan pool was therefore co-digest-
ed with jack bean α-mannosidase which cleaves terminal 
α-(1,2), α-(1,3) and α-(1,6)-mannoses, thus  simplifying the 
glycan structures. A main product structure with a mass 
of 1095 was detected, corresponding with the mass ex-
Figure 3 a Xylotetraose (X4) binding to B. subtilis arabinoxylan arabinofuranohydrolase BsAXH-m2,3 (PDB 3C7G) b Superimposition of 
XynD over 3C7G with X4 ligand c Arabinohexaose (A6) binding to C. japonicus alpha-L-arabinase Abf43A (PDB 1GYE) d Superimposition of 
XynD over 1GYE with A6 ligand. 
pected for the sodiated retainment of Galf-α-(1,2)-Man-α-
(1,3)-Man-α-(1,6)-Man-β-(1,4)-GlcNAc-β-(1,4)-GlcNAc, thus 
confirming that glycan structures terminated with Galf (or 
potentially other non-mannose residues) were obtained. 
However, no reaction products were  observed after incu-
bation of this substrate with XynD, confirming XynD is not 
active on these Galf N-glycans.
We conclude that the natural substrate of XynD may either 
be a disaccharide or consist of a glycan with a different link-
age type from β-(1,5), β-(1,6) or α-(1,2), for example such 
as β-(1,2)-linked Galf as found in glycoinositolphospholipids. 
Biochemical characterization
Using Galf-pNP as a model  substrate,  we assessed the 
optimum reaction conditions and  kinetic parameters for 
XynD. The enzyme exhibited its highest activity at pH 4-5, 
as  assessed after incubation of purified XynD at 25 °C for 
1 h in a range of citrate-phosphate buffers at pH 3-9 (Fig. 
4A). At pH >5 the enzyme showed substantial reduction in 
activity. This is similar to a previously described A. niger β-D-
galactofuranosidase that demonstrated optimal activity at 
pH 3-432. XynD temperature optimum was 25 °C (Fig. 4B) with 
substantial decrease in activity observed after incubation at 
temperatures greater than 30 °C. The temperature stability 
of XynD decreased when incubated above 30 °C for 1 h (Fig. 
S8).
The specific activity of XynD against pNP-β-Galf at 25 °C, pH 
5 was 0.23 μmol min−1 mg−1. The activity appears to follow Mi-
chaelis-Menten kinetics, displaying a Km of 17.9 ± 1.9 mM, 
Vmax of 70.6 ± 5.3 µM min
−1 and Kcat of  0.14 s
-1.
Discussion
Galf containing glycans such as galactomannan or O-glycans 
are important as drug targets and immunogenic motifs in 
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Figure 4: Optimisation of reaction conditions for pNP-Galf hydrolysis by XynD a Relative activity at pH 3-9 b Relative activity at tempera-
tures 4-70 °C 
the production of pharmaceuticals due to the absence of 
the Galf monosaccharide in mammalian tissues23. There has 
therefore been a longstanding interest in elucidation of the 
enzymatic mechanism contributing to the turnover of such 
glycans1. 
Galactomannan degrading activity of an unidentified en-
zyme produced by A. niger has been previously reported32. 
Subsequent investigation to identify this source of activ-
ity has revealed a variety of Galf active enzymes within the 
Aspergillus genus. A. niger AbfA and AbfB both have dual 
activity against pNP-Galf and pNP-Araf yet do not degrade 
galactomannan33. More recently, A. nidulans exo-acting Gal-
fases GfgA and GfgB have been identified, and have been 
shown to hydrolyze both β-(1,5) and β-(1,6) linkages, whilst 
A. fumigatus Afu2g14520 demonstrates dual activity against 
pNP-Galf and pNP-Araf, with higher activity against the lat-
ter34. Here we demonstrated that XynD encodes an galac-
tofuranosidase active against pNP-Galf. The enzyme is not 
responsible for galactomannan degradation and lacks activ-
ity against β-(1,5), β-(1,6)- and α-(1,2) linked Galf substrates. 
Instead its activity suggests glycoinositolphospholipids may 
be the natural substrate.
XynD has previously been annotated as a putative xylosidase 
in the literature and our identification of its galactofurano-
sidase activity highlights how detailed phylogenetic analysis 
combined with biochemical  characterization is critical  to un-
derstand the roles of glycoside hydrolases. Our phylogenetic 
analysis of the subfamily, followed by mapping of biochemi-
cally characterized members, demonstrated how GH43-34 
is grouped into multiple clusters containing characterized 
members with arabinofuranosidase activity.  Assignment of 
Cluster I members as arabinofuranosidases was further sup-
ported by  association of a subset of members from this clus-
ter with CBM42, which are commonly associated with GH54 
arabinofuranosidases and bind arabinofuranose present in 
arabinoxylan46. Only cluster II contained bacterial members 
with galactofuranosidase activity and our structural mod-
elling, substrate docking and biochemical characterization 
confirmed our hypothesis that as fungal member of this clus-
ter, XynD, had galactofuranose activity. 
Previously studies of GH family 43 reveal only the catalyt-
ic residues (Asp, Glu, and its pKa-modulating Asp) are well 
conserved42, and our molecular docking studies confirm the 
binding pose of galactofuranose in XynD is stabilized to these 
from local Asp, Glu, Trp and Arg residues. In XynD, many 
potential subsites are completely occluded by surround-
ing loops between separate beta-strands and thus explains 
the lack of catalysis demonstrated against large oligo- and 
polysaccharides. The variety of specificities observed in the 
GH43 family stem from the variable orientation of which the 
substrate can sit within the deep pocket of the active site, 
thus resulting in a diverse and complex family47,48. 
Our modelling of the XynD structure combined with se-
quence alignments highlighted how an amino acid in the ac-
tive site of the GH43-34, is consistently different between 
the arabinofuranosidases and galactofuranosidases and 
could affect the substrate specificity in the GH43-34 subfam-
ily. This W219, whose equivalent is a T in arabinofuranosi-
dases,  is positioned to affect sugar binding in the subsite 
and we hypothesised that mutation of this site may switch 
enzyme activity from a galactofuranosidase to and arabino-
furanosidase. Attempts to a form a W219T mutant of XynD 
were unsuccessfull due to a lack of protein production from 
a mutant plasmid. 
XynD was the first fungal member of GH family 43-34 to be 
recombinantly expressed and biochemically characterized. 
We showed XynD demonstrates hydrolytic activity against 
pNP-Galf. Interestingly, despite the substantial structural 
similarities between Galf and Araf, XynD does not show ac-
tivity against pNP-Araf and is thus thereby differs from other 
characterized A. niger galactofuranosidases that exhibit dual 
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activity33. An unidentified A. niger enzyme with Galfase ac-
tivity has been studied32. The enzyme is substantially larger 
than XynD at ~80 kDa (after N-glycan removal by EndoH 
treatment), although this difference could be accounted for 
by the presence of O-linked glycans. The unidentifed Galfase 
exhibits a lower a Km (4 mM) in comparison to that of XynD 
(17.9 mM), and therefore likely is a different enzyme from 
XynD.
XynD displays an optimum pH between pH 4 and pH 5, and 
concurs with previously described recombinant galacto-
furanosidases  with varying optimum pHs of 3-728,30,34,49,50. 
Optimal temperature of characterized galactofuranosidases 
vary, for example, the Galf-ase derived from Streptomyces 
sp. JHA26 lost its activity when incubated at a temperature 
over 45 °C whilst Streptomyces sp. JHA19 galactofuranosi-
dases had an optimal temperature at 60 °C50,51. Since XynD 
was expressed in E. coli no post translational modifications, 
such as glycosylation, will have occurred. Therefore, lack of 
post translational modifications should be considered when 
evaluating parameters such as activity, pH optimum and 
temperature optimum.  
To gain more insight in the biological role of XynD, we as-
sessed the conditions under which xynD expression and 
XynD secretion has been reported. Gene co-expressing 
networks, based on 155 transcriptomics experiments52 and 
available via FungiDB, highlighted expression of xynD is posi-
tively correlated with 110 genes, and gene ontology (GO) 
enrichment analysis using REViGO53 (Fig. S9) revealed that 
these are enriched  for transmembrane transporter activ-
ity (GO:0022857), oxidoreductase activity (GO:0016491), 
hydrolase activity, acting on glycosyl bonds (GO:0016798) 
and hydrolase activity with activity on carbon-nitrogen (but 
not peptide) bonds (GO:0016810). This  positive correlation 
suggest xynD is expressed during carbohydrate degradation. 
In A. niger, xynD expression has previously been reported 
to be induced in response to plant-derived polysaccharides 
and lignocellulose, despite lack of putative binding sites in 
its promoter for the master regulator XlnR.  Low levels of 
expression xynD are observed on a variety of easily metabo-
lised carbon sources (glucose, sucrose, fructose and sugar 
beet pulp) and expression is suspected to be subject to car-
bon catabolite repression, as supported by 11 binding sites 
for carbon catabolite repressor CreA in the promotor region 
of xynD54 and other genes undergoing such repression55. 
Whilst xynD is not expressed during growth on maltose in 
the fungal wild-type55, mutants with an inactivated amyR 
(encoding a regulator of starch degradation induced by malt-
ose56) display upregulation of xynD transcription55. Similarly, 
xynD expression on arabinose is low in the wild-type, but an 
araR disruption mutant showed upregulation of xynD tran-
scription55. In the amyR57 and araR58 mutants the expression 
of sugar transporters and metabolic enzymes that enable 
growth on maltose and arabinose, respectively, will be nega-
tively affected and thus the observed expression pattern is 
consistent with a response to carbon limitation and concurs 
with the expression response to starvation in other A. niger 
galactofuranosidases32. 
In conclusion, this study revealed further insight into the 
degradation of galactofuranose containing biomolecules 
with the identification of a GH43-34 A. niger galactofuran-
osidase. Understanding this vast but largely undescribed 
subfamily could play a key role in developing knowledge of 
glycosylation in a variety of fungal products, such as phar-
maceuticals.
Experimental procedures
Phylogenetic analysis of XynD
GH 43-34 domains were identified using the Pfam data base59 
then subsequently aligned and trimmed to just the catalytic 
domain using BioEdit60. Evolutionary analyses were conduct-
ed in MEGA X61. The evolutionary history was inferred by us-
ing the Maximum Likelihood method and JTT matrix-based 
model62. Initial tree(s) for the heuristic search were obtained 
automatically by applying Neighbour-Join and BioNJ algo-
rithms to a matrix of pairwise distances estimated using the 
JTT model, and then selecting the topology with superior log 
likelihood value. The tree was drawn to scale, with branch 
lengths measured in the number of substitutions per site. 
This analysis involved 963 amino acid sequences. There were 
a total of 494 positions in the final dataset. 
Computational docking studies
Enzyme modelling and molecular docking simulation was 
performed using the YASARA software from YASARA Biosci-
ences GmbH. As there is no PDB structure of XynD a model 
was produced using Bacteroides thetaiotaomicron endo-1,4-
beta-xylanase D (PDB 3QZ4) as a template and was subse-
quently used to generate the receptor for simulations. In 
all cases, the raw crystal structures were first prepared for 
simulation using the YASARA „Clean“ script, which detects 
and amends crystallographic artefacts and assigns proton-
ation states. Before docking, the energy minimization script 
of the YASARA software package was applied to the protein 
in order to obtain the most likely starting structure. For en-
ergy minimization, a simulation cell was defined around the 
whole protein and the cell was filled with water molecules. 
For docking, the water was removed afterwards with a vari-
ety of arabinose and galactofuranose based docking ligands. 
Ligands were minimised in vacuo using the energy minimi-
zation script of the YASARA software package. The docking 
simulation itself was performed using the dock_run.mcr 
macro using VINA as the docking method and the AMBER03 
force field. Appropriate simulation cells were defined for the 
respective docking simulations. The created receptor-ligand 
complex structures were further processed using the PyMOL 
software from Schrodinger LLC involving the identification of 
polar contacts between the ligand and the receptor, as well 
as determination of bond distances.
Construction of expression vectors
The gene xynD (An11g03120, GenBank: CAK40644.1), with 
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an 86 bp intron removed, was synthesised by GeneArt gene 
synthesis (Thermo Fisher scientific) with codon optimisa-
tion for expression in Pichia pastoris. Construct included 5’ 
and 3’ complementary overhangs for ligation into pPICZαA 
using NEBuilder HiFi DNA Assembly (New England Biolabs) 
to form pPICZαA_GH43_34. The coding sequence of xynD 
gene was amplified from pPICZαA_GH43_34 using prim-
ers 5’ CGCCATATGCACCCACAACAGAACTTG-3’ (forward) and 
5’-CGCCTCGAGAGACAAAGTTCTACCCTCGACAC-3’ (reverse). 
The primers contained restrictions sites NdeI and XhoI (un-
derlined) for forward and reverse primers, respectively. The 
PCR conditions were as follows: initial denaturation 95 °C (5 
min), [95 °C (30 s) denaturation, 58 °C (30 s) annealing and 
72 °C (30 s) extension] for 20 cycles, final extension 5 min. 
PCR amplifications were conducted using Phusion DNA poly-
merase. The resulting products were run on 1 % agarose gel 
then extracted using QIAquick Gel Extraction Kit (Qiagen). 
Restriction enzymes and Phusion DNA polymerase were 
purchased from New England BioLabs Inc and used accord-
ing to the manufacturer’s instructions. The amplified frag-
ment was cloned into linearized (NdeI and XhoI) pET21a to 
form pET21a_43_34. Correct insertion of the gene in the ex-
pression vector was  confirmed by sequencing. The amino 









Protein expression and purification
E. coli strain Rosetta™(DE3) carrying pET21a_43_34 was in-
oculated into LB media supplemented with 100 ug ml-1 am-
picillin and grown at 37 oC, 250 rpm until OD600 ~0.25. Cells 
were then induced with 1mM IPTG final concentration and 
grown at 22 oC, 250 rpm for 16 h. Cells were harvested by 
centrifugation (4000 rpm, 15 min, 4 °C), suspended in His-buffer 
(Tris 50 mM, NaCl 250 mM, imidazole 20 mM, pH 8) and lysed by 
sonication (20s on, 20s off, 5 min). Cell debris was removed 
by centrifugation (4000 rpm, 15 min, 4 °C). Protein was purified 
by metal affinity chromatography on a Ni2+-NTA column 
(Qiagen). Cell free extract was loaded onto column fol-
lowed by two wash steps with wash buffer (Tris 50 mM, 
NaCl 250 mM, imidazole 20 mM, pH 8) followed by applica-
tion of elution buffer (Tris 50 mM, NaCl 250 mM, imidazole 
200 mM, pH 8), all fractions were retained for SDS-PAGE 
analysis. The his-tagged purified protein was then further 
purified using anion exchange chromatography employing a 
HITrapQ HP column 1 mL, whereby the protein was eluted 
with a gradient of 20 mM Tris-HCl buffer, 0.5M NaCl, pH 7.2. 
Eluted proteins were analysed by 4—15% sodium dodecyl 
sulfate polyacrylamide (SDS-PAGE) gel electrophoresis (Mini-
PROTEAN® TGX™ Precast Gels by Bio-rad) using broad range 
molecular weight markers (PageRuler™ Plus Prestained Pro-
tein Ladder) as standard, and the protein bands were visu-
alised by staining with Coomassie Brilliant Blue G250. The 
protein concentration was determined by Bradford method 
using bovine serum albumin (BSA) as a standard based on 
the protocol provided by Sigma-Aldrich (96 Well Plate Assay 
Protocol). All experiments presented in this manuscript were 
performed with XynD purified by anion exchange chroma-
tography unless otherwise stated.
Mass spectrometry of carbohydrates
Samples were prepared for analysis by MALDI-TOF via 
crystallisation with super DHB or THAP matrices. Super 
DHB (a 9:1 (w/w) mixture of 2,5-Dihydroxybenzoic acid and 
2-hydroxy-5-methoxybenzoic acid) was prepared at 15 mg 
ml-1 in a mixture of 50 % (v/v) acetonitrile and 50 % (v/v) 
water containing 0.1 % trifluoroacetic acid (TFA). 2′,4′,6′-Tri-
hydroxyacetophenone monohydrate (THAP) was prepared at 
10 mg ml-1  in acetone. MALDI-TOF mass spectrometry was 
performed using the Bruker Ultraflex 3 in positive mode. 
MALDI-TOF was calibrated using peptide Calibration Stan-
dard II (Bruker) containing a range of peptides 757-3149 Da 
in size.
Substrate specificity
XynD (0.5 mg ml-1) was incubated overnight at 25 °C in 50 
mM citric acid-phosphate pH 5 with pNP-labelled sub-
strates at 1 mM. All experiments were performed in trip-
licate. Reactions were halted via a 1:1 volume addition 
of Na2CO3 1M with pNP release measured at OD405. The 
following substrates were used: pNP-β-ᴅ-galactofuranoside 
(pNP-β-ᴅ-Galf; Carbosynth), pNP-α-ʟ-arabinofuranoside 
(pNP-α-ʟ-Araf; Megazyme), pNP-β-galactopyranoside (pNP-
β-Galp; Sigma-Aldrich), pNP-β-glucopyranoside (pNP-β-Glcp; 
Sigma-Aldrich), pNP-α-glucopyranoside (pNP-α-Glcp; Sigma-
Aldrich), pNP-N-acetyl-β-D-glucosaminide (pNP-β-ᴅ-GlcNAc; 
Sigma-Aldrich), pNP-lactose (pNP-Lac; Sigma-Aldrich), pNP-
xylopyranoside (pNP-Xylp; Sigma-Aldrich), pNP-xylobiose 
(pNP-β-Xyl2, Carbosynth) , pNP-β-(1,5)-Galf-β-(1,5)-Galf-β-
(1,5)-Galf (pNP-β-(1,5)-Galf3); gift of Dr. T. Oka.
XynD (0.5 mg ml-1) was incubated overnight at 25 °C in 
50 mM citric acid-phosphate pH 5 with the following 
4MU-labelled substrates at 1 mM: 4MU-Galf3, 4MU-Galf4, 
4MU-Galf5, 4MU-Galf6, (gifts of Dr. T. Oka, Sojo University, Ja-
pan). Reactions were halted by the addition of stop solu-
tion (1M sodium hydroxide, 1M glycine, pH 10) with released 
4-MU detected after excitation at 365 nm and emission at 
440 nm.
XynD (0.5 mg ml-1) was incubated overnight with 1 mM 
final concentration Octyl β-D-Galactofuranosyl-(1,6)-β-D-
galactofuranosyl-(1,5)-β-D-galactofuranoside and Octyl 
β-D-Galactofuranosyl-(1,5)-β-D-galactofuranosyl-(1,6)-β-D-
galactofuranoside (gifts of Dr. T.L. Lowary, The Institute of 
Biological Chemistry, Academia Sinica, Taiwan) in 50 mM cit-
ric acid-phosphate buffer. Reaction were then monitored by 
MALDI-TOF MS.
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The α-(1,2)-Galf-containing N-linked glycans were released 
from 1 mg Transglucosidase L “Amano” (Amano) by using 
PNGase F (New England Biolabs) under denaturing condi-
tions. Reactions were then filtered via Vivaspin 500 
(Sigma-Aldrich) to obtain the glycan products. Samples 
were then purified using a 1 ml Supelclean™ ENVI-
Carb™ SPE Tube. The column was prepared with 1 ml of 
each solution in a sequential order: 75% acetonitrile + 
0.1% trifluoroacetic, 1 M NaOH, water, 30% acetic acid, wa-
ter, 75% acetonitrile + 0.1% trifluoroacetic. The sample was 
then applied and washed with 3 column volumes of water 
followed by subsequent elution with 3 mL 25% acetonitrile 
+ 0.1 % trifluoroacetic acid. The N-linked glycans were then 
dried and resuspended in water. Glycans were incubated 
with final concentation 1 mg ml-1 XynD in 50 mM citric acid-
phosphate buffer, pH 5 overnight, then analysed by MALDI-
TOF MS. Additionally glycans were co-incubated with 1 mg 
ml-1 XynD and  1 mg ml-1 α-Mannosidase from Canavalia en-
siformis (Sigma-Aldrich).
Activity of XynD on A. niger galactomannan, a kind gift from 
Dr A. Ram and J. Park (The University of Leiden, the Nether-
lands), was assessed via overnight incubations containing fi-
nal concentration 0.5 mg ml-1 XynD and 1 mg ml-1 A. niger 
N402 galactomannan in 50 mM citric acid-phosphate 
buffer at 25 °C. Reactions were then filtered via Vivaspin 
500 (Sigma-Aldrich) to remove protein from the reac-
tions. Galactomannan, hydrolysed via incubation in tri-
fluoroacetic acid  at 100 °C for 5 h acted as a positive control 
for detection of constituant monosaccharides XynD activity 
was assessed via detection of released galactose by HPAEC-
PAD as described in detail below, and via Platelia™ Aspergil-
lus Ag (Bio-Rad), as detailed by the manufacturer.  
HPAEC-PAD analysis
High performance anion exchange chromatography (HPAEC) 
was performed to analyze monosaccharide release by XynD, 
based on a published method63. A Thermo Scientific Dionex 
ICS-6000 HPAEC system with pulse amperometric detection 
(PAD) controlled by Chromeleon software version 7.1 was 
used. A CarboPac PA1 guard (2 mm x 50 mm, Thermo Fisher 
Scientific) and a CarboPac PA1 analytical column (250 mm × 
2 mm, Thermo Fisher Scientific) for monosaccharide analysis 
were employed. Monosaccharides were eluted isocratically 
using H2O and 1M NaOH in a ratio of 80:20 for 30 min with a 
flow rate of 0.25 ml min-1.
Identification of pH and temperature optimum and stability
To identify the optimal pH for activity, 1 mM pNP-β-Galf was 
incubated with XynD (0.5 mg ml-1) for 1 h at 25 °C in 50 mM 
citric acid-phosphate and Tris-HCl buffers at a range of pH 
4-9. Reactions were halted via a 1:1 volume addition of 1M 
NaCO3, after which pNP release as measured at OD405. To 
identify the optimal reaction temperature, reactions were 
incubated in 50 mM pH 5 citric acid-phosphate buffer at a 
range of temperatures from 4-90 °C. All experiments per-
formed in triplicate and enzyme activity was linear over time 
under the conditions described. pH stability was determined 
via pre-incubation of the enzyme (0.3 mg ml-1) for 1 h at pH 
3-9 before assaying residual activity on pNP-Galf under stan-
dard condition reactions at pH 5.
Co-expression analysis of XynD
A. niger microarray data from FungiDB was used to elucidate 
co-expression networks. Spearman scores of 0.5 of greater 
are considered significantly co-expressed.  1241 / 110 genes 
showed a positive correlation with the xynD gene (Spearman 
coefficient ≥ 0.5 / ≥ 0.75) and 1476 / 70 genes a negative cor-
relation (Spearman coefficient ≥−0.5 / ≥−0.75).
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